Rationale for combinatory chronic lymphocytic leukaemia treatment paradigms in the era of the B-cell receptor pathway and anti-apoptotic inhibitors: how do we mix, match, and move forward?
Publication
, Journal Article
Brander, DM
Published in: Br J Haematol
February 2017
Duke Scholars
Published In
Br J Haematol
DOI
EISSN
1365-2141
Publication Date
February 2017
Volume
176
Issue
3
Start / End Page
337 / 340
Location
England
Related Subject Headings
- Receptors, Antigen, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Immunology
- Humans
- B-Lymphocytes
- Apoptosis
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Brander, D. M. (2017). Rationale for combinatory chronic lymphocytic leukaemia treatment paradigms in the era of the B-cell receptor pathway and anti-apoptotic inhibitors: how do we mix, match, and move forward? Br J Haematol, 176(3), 337–340. https://doi.org/10.1111/bjh.14446
Brander, Danielle M. “Rationale for combinatory chronic lymphocytic leukaemia treatment paradigms in the era of the B-cell receptor pathway and anti-apoptotic inhibitors: how do we mix, match, and move forward?” Br J Haematol 176, no. 3 (February 2017): 337–40. https://doi.org/10.1111/bjh.14446.
Brander DM. Rationale for combinatory chronic lymphocytic leukaemia treatment paradigms in the era of the B-cell receptor pathway and anti-apoptotic inhibitors: how do we mix, match, and move forward? Br J Haematol. 2017 Feb;176(3):337–40.
Brander, Danielle M. “Rationale for combinatory chronic lymphocytic leukaemia treatment paradigms in the era of the B-cell receptor pathway and anti-apoptotic inhibitors: how do we mix, match, and move forward?” Br J Haematol, vol. 176, no. 3, Feb. 2017, pp. 337–40. Pubmed, doi:10.1111/bjh.14446.
Brander DM. Rationale for combinatory chronic lymphocytic leukaemia treatment paradigms in the era of the B-cell receptor pathway and anti-apoptotic inhibitors: how do we mix, match, and move forward? Br J Haematol. 2017 Feb;176(3):337–340.
Published In
Br J Haematol
DOI
EISSN
1365-2141
Publication Date
February 2017
Volume
176
Issue
3
Start / End Page
337 / 340
Location
England
Related Subject Headings
- Receptors, Antigen, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Immunology
- Humans
- B-Lymphocytes
- Apoptosis
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology